Replies to post #3529 on Insmed Inc (INSM)

[elmono]

Appreciate your response and yes there might be many reasons that explain 'low' initial uptake and also lower revs.

Remember that the 33 or 66 patient number I referred were not invented by me, but calculated by another poster.

The facts are that

1) INSMED expected to have 200 patient*years worth of revs for 2006. (200*40.000 gives you 8 million)

2) INSMED now states during trial that revs for 2006 are less than 1 million.

So what changed that could not have been foreseen by INSM when they made their initial calculations?

I guess we'll just have to patiently wait for Q4 figures to come in and provide us with more guidance as to were we stand and what the real potential of the current approved indication is.

Regards,

Elmono

( I appreciate that you directed your warning to all 'off topic' posters :-)